Bioactive Substances from Medicinal Plants for Metabolic Disorders
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.6/9286 |
Resumo: | Metabolic disorders, particularly Diabetes Mellitus (DM), are major causes of death worldwide. In fact, the world statistics for DM are alarming: this epidemic disease kills one person every six seconds, being the fourth cause of death. Besides the health issues, the costs associated with DM, and its co-morbidities, are massive and the pressure in National Health Care Systems is dramatically increasing. Patients with DM, particularly those with type 2 diabetes (T2D), are primarily advised to change their dietary habits and exercise regime. However, as the disease progresses and becomes more severe, conventional drugs are prescribed. Most of these patients need polypharmacological therapy and though progresses have been made, efforts are mandatory in a search for a “perfect” antidiabetic drug. [...] |
id |
RCAP_7e09e548633127f1127af75272b9f052 |
---|---|
oai_identifier_str |
oai:ubibliorum.ubi.pt:10400.6/9286 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Bioactive Substances from Medicinal Plants for Metabolic DisordersEditorialCoffeeHumansIsoflavonesMetabolic DiseasesPhenolsPlants MedicinalQuercetinMetabolic disorders, particularly Diabetes Mellitus (DM), are major causes of death worldwide. In fact, the world statistics for DM are alarming: this epidemic disease kills one person every six seconds, being the fourth cause of death. Besides the health issues, the costs associated with DM, and its co-morbidities, are massive and the pressure in National Health Care Systems is dramatically increasing. Patients with DM, particularly those with type 2 diabetes (T2D), are primarily advised to change their dietary habits and exercise regime. However, as the disease progresses and becomes more severe, conventional drugs are prescribed. Most of these patients need polypharmacological therapy and though progresses have been made, efforts are mandatory in a search for a “perfect” antidiabetic drug. [...]uBibliorumSilva, Branca M.Oliveira, Pedro F.Alves, Marco GDias, Tânia R.2020-02-17T12:26:49Z20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.6/9286eng10.2174/092986732404170302223350info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-11-27T12:31:18Zoai:ubibliorum.ubi.pt:10400.6/9286Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-27T12:31:18Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Bioactive Substances from Medicinal Plants for Metabolic Disorders Editorial |
title |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
spellingShingle |
Bioactive Substances from Medicinal Plants for Metabolic Disorders Silva, Branca M. Coffee Humans Isoflavones Metabolic Diseases Phenols Plants Medicinal Quercetin |
title_short |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
title_full |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
title_fullStr |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
title_full_unstemmed |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
title_sort |
Bioactive Substances from Medicinal Plants for Metabolic Disorders |
author |
Silva, Branca M. |
author_facet |
Silva, Branca M. Oliveira, Pedro F. Alves, Marco G Dias, Tânia R. |
author_role |
author |
author2 |
Oliveira, Pedro F. Alves, Marco G Dias, Tânia R. |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
uBibliorum |
dc.contributor.author.fl_str_mv |
Silva, Branca M. Oliveira, Pedro F. Alves, Marco G Dias, Tânia R. |
dc.subject.por.fl_str_mv |
Coffee Humans Isoflavones Metabolic Diseases Phenols Plants Medicinal Quercetin |
topic |
Coffee Humans Isoflavones Metabolic Diseases Phenols Plants Medicinal Quercetin |
description |
Metabolic disorders, particularly Diabetes Mellitus (DM), are major causes of death worldwide. In fact, the world statistics for DM are alarming: this epidemic disease kills one person every six seconds, being the fourth cause of death. Besides the health issues, the costs associated with DM, and its co-morbidities, are massive and the pressure in National Health Care Systems is dramatically increasing. Patients with DM, particularly those with type 2 diabetes (T2D), are primarily advised to change their dietary habits and exercise regime. However, as the disease progresses and becomes more severe, conventional drugs are prescribed. Most of these patients need polypharmacological therapy and though progresses have been made, efforts are mandatory in a search for a “perfect” antidiabetic drug. [...] |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2017-01-01T00:00:00Z 2020-02-17T12:26:49Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.6/9286 |
url |
http://hdl.handle.net/10400.6/9286 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.2174/092986732404170302223350 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817549640591998976 |